Stay updated with breaking news from Oral Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mumbai, Baltimore, October 12, 2023: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for...
At the end of each week, the law firm d’Oliveira & Associates compiles a summary of recalls, FDA warnings, market withdrawals and safety alerts that the public should be aware of for their …
Novartis has voluntarily recalled 1 lot of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to crystal formation.
Novartis is conducting a voluntary nationwide recall at the consumer level of one lot of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. No other Sandimmune for
Alkem recalled 99,516 sachets of antibiotic used to treat bladder infections and Caplin recalled 19,820 vials of heart medication according to US FDA Enforcement Report